#153999

Anti-CEACAM21 [1E4]

Cat. #153999

Anti-CEACAM21 [1E4]

Cat. #: 153999

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Human CEACAM 21

Class: Monoclonal

Application: ELISA ; FACS ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Bernhard B. Singer

Institute: LeukoCom

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-CEACAM21 [1E4]
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; FACS ; WB
  • Immunogen: Recombinant soluble human CEACAM 21-Fc produced in HEK293 Transfectants
  • Isotype: IgG1 kappa
  • Myeloma used: NS1/0

Target Details

  • Target: Human CEACAM 21

Applications

  • Application: ELISA ; FACS ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Tchoupa et al. 2014. Cell Commun Signal. 12:27. PMID: 24735478.
  • Signaling by epithelial members of the CEACAM family - mucosal docking sites for pathogenic bacteria.
  • Genetics of sputum gene expression in chronic obstructive pulmonary disease.
  • Qiu et al. 2011. PLoS One. 6(9):e24395. PMID: 21949713.
  • Zebhauser et al. 2005. Genomics. 86(5):566-80. PMID: 16139472.
  • Identification of a novel group of evolutionarily conserved members within the rapidly diverging murine Cea family.
  • Fukuda, I., Yamakado, M. & Kiyose, H. Journal of Medical Systems (1998) 22: 89.